16Jun 2018

EVALUATION OF COAGULATION PROFILE IN PATIENTS WITH PREGNANCY INDUCED HYPERTENSION IN PATIENTS ATTENDING A TERTIARY CARE HOSPITAL IN NORTH INDIA.

  • Department of Obstetrics and Gynaecology, Sher-e-Kashmir Institute of Medical Sciences (SKIMS), Soura J&K.
  • Department of General and minimal access Surgery, ,Sher-e-Kashmir Institute of Medical Sciences(SKIMS), Soura J&K.
Crossref Cited-by Linking logo

  • Abstract
  • References
  • Cite This Article as
  • Corresponding Author

Pregnancy induced hypertension (PIH) is one of the most common causes of both maternal and neonatal morbidity and associated with adverse pregnancy outcomes.Profound changes in coagulation and fibrinolytic system occur during normal pregnancy causing hypercoagulable state. Early identification of high risk women and monitoring derangements in their coagulation system are surely pivotal in the prevention of complications. Hence, this study was undertaken to compare the coagulation profile in pre-eclamptic and eclamptic patients with normotensive pregnant patients Hypertension is one of the common medical complications of pregnancy and contributes significantly to maternal and perinatal morbidity and mortality. Hypertension is a sign of an underlying pathology which may be pre-existing or appear for the first time during pregnancy. Various haematological changes like numerical and functional platelet abnormalities, alteration in haemoglobin and erythrocyte parameters and hypercoagulable state may be seen. Aims and Objectives: Evaluation of coagulation profile in PIH. Materials and Methods: A one year study was carried in the department of gynaecology and obstetrics on 100 PIH cases. Coagulation profile (PT, aPTT, INR and D-dimer) was done in all cases and values were correlated with the severity of PIH. Results: Total of 100 cases were included in the study. 32 were mild GH, 17cases were severe GH, 35 cases were mild pre-eclampsia and 16cases were in severe pre-eclampsia group. Prolonged PT, aPTT and D-Dimer was seen in 15 cases, 42 cases and 38 cases respectively. In our study we observed increased mean aPTT of 31.61+-2.89 and increased D-Dimer of 0.34?0.31 in severe pre-eclampsia patients. Hence we emphasize that raised aPTT, D-Dimer are alarming signs for aggressive treatment. Conclusion: Raised aPTT and D-dimer are fairly good indicator of severe pre-eclampsia and needs aggressive treatment.

  1. Khan ks?WojdylaD,Etal.WHO analysis of causes of maternal death;a systematic review.Lancet.2006;367;1066.
  2. Shah M R. Hypertensive disorders in pregnancy. 1st edn published by Jaypee. 2007: 1-10 3. Cunningham F G, Leveno K J, Bloom S L, Hauth J C, Gilstrap III. L.C, Wenstrm K. D. Hypertensive disorders in pregnancy. Ch 37 In William Obstetrics. 21st edn published by McGraw Hill Company; 2002: 871-90.
  3. Cunningham F.G, Kenneth J. Leveno, StevenL.Bloom, John C. Pregnancy induced hypertention. In: Kenneth J. Leveno, StevenL.Bloom editor. William Obstetrics, 23rd ed. New York:McGraw-Hill; 2010. p. 706-56.
  4. Dutta D C. Pregnancy induced hypertention. In:Dutta DC editor. Textbook of Obstretrics including Perinatalogy and Contaception, 7th ed. Kolkata:New Central Book Agency(P)Ltd; 2011. p. 219-40.
  5. Norwitz ER, Hsu CD, RepkeJT.Acute complications of preeclampsia.ClinObstetGynecol2002;45:308-29.
  6. Onisai M, VladareanerAM, Bumbea H, Clorascu M, Pop C, AndreiC, et al. A study of haematological picture and of platelet function in preeclampsia-report of a series of cases. J of Clin Med 2009;4:326-7.
  7. Weiner CP, Brandt J. Plasma antithrombin-III activity: An aid in the diagnosis of pre-eclampsia-eclampsia. Am J ObstetGynecol 1982; 142:275-81.
  8. Jahromi BN, Rafiee SH. Coagulation factors in severe preeclampsia. IRCMJ 2009; 11(3):321-4. 8. FitzGerald MP, Floro C, Siegel J, Hernandez E. Laboratory findings in hypertensive disorders of pregnancy. J Nat Med Assoc 1996; 88(12):794-98.
  9. Osmond C, Kajantie E, Fors?n TJ, Eriksson JG, Barker DJ. Infant growth and stroke in adult life: The Helsinki Birth Cohort Study. Stroke 2007; 38(2):264-70
  10. Norwitz ER, Hsu CD, RepkeJT.Acute complications of preeclampsia.ClinObstetGynecol2002;45:308-29.
  11. Metz J, Cincotta R, Francis M, DeRosa L, Balloch A. Screening for consumptive coagulopathy in preeclampsia. Int J GynecolObstet 1994;46:3-9.
  12. Barron WM, Heckerling P, Hibbard JU, Fisher S. Reducing unnecessary coagulation testing in hypertensive disorders of pregnancy. ObstetGy-necol 1999;94:364-70.
  13. Leduc L, Wheeler JM, Kirshon B, Mitchell P, Cotton DB. Coagulation profile in severe preeclampsia. ObstetGynecol 1992;79:14-8.
  14. Kramer RL, Izquierdo LA, Gilson GJ, Curet LB, Qualls R. "Preeclamptic labs" for evaluating hypertension in pregnancy. J ReprodMed 1997;42:223-8.
  15. Osmanagaoglu MA, Top?uoglu K, Ozeren M, Bozkaya H. Coagulation inhibitors in preeclamptic pregnant women. Arch GynecolObstet 2005;271:227-30.
  16. Fitzgerald MP, Floro C, Siegel J, Hernandez E. Laboratory Findings in hypertensive disorders of pregnancy. J Natl Med Assoc 1996;88:794-98.
  17. Kobayashi T, Tokunaga N, Sugimura M, Kanayama N, Terao T. Predictive Values of Coagulation/Fibrinolysis Parameters for the Termination of Pregnancy Complicated by severe preeclampsia. SeminThrombHemosst 2001;27:137-41

[Farhat Ali Lone, Sabha Malik, Shaheera Ajaz, Liaqat Ahmad Malik And Parvaiz Mohiudin Dar. (2018); EVALUATION OF COAGULATION PROFILE IN PATIENTS WITH PREGNANCY INDUCED HYPERTENSION IN PATIENTS ATTENDING A TERTIARY CARE HOSPITAL IN NORTH INDIA. Int. J. of Adv. Res. 6 (Jun). 501-506] (ISSN 2320-5407). www.journalijar.com

DR FARHAT ALI LONE
SHER-I-KASHMIR INSTITUTE OF MEDICAL SCIENCES

DOI:

Article DOI: 10.21474/IJAR01/7237      
DOI URL: https://dx.doi.org/10.21474/IJAR01/7237

Download Full Paper

Download PDF No. of Downloads: 56 | No. of Views: 204